droperidol has been researched along with methylprednisolone in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (33.33) | 18.7374 |
| 1990's | 3 (20.00) | 18.2507 |
| 2000's | 3 (20.00) | 29.6817 |
| 2010's | 4 (26.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Nagahata, T; Shimokawa, M; Suzuki, A | 1 |
| Fujii, M; Kiura, K; Okabe, K; Tamai, M; Toki, H | 1 |
| Adachi, K; Mashiko, N; Minami, T; Murata, N; Onodera, T; Sato, T; Yazawa, C | 1 |
| Akaza, H; Aso, Y; Fujita, K; Isurugi, K; Kawabe, K; Kinoshita, K; Koiso, K; Kondo, Y; Niijima, T; Yokoyama, M | 1 |
| Bagnoli, P; Giusti, L; Maffei, F; Mariani, F; Santoi, F | 1 |
| Catalano, RB; Dambra, J; Grossman, B; Mason, BA | 1 |
| Akutagawa, N; Fukunaka, N; Hayashi, T; Kitajima, Y; Kudo, R; Mizumoto, H; Nakamura, T; Sagae, S; Sugimura, M; Terasawa, K; Wataba, K; Yamana, K | 1 |
| Cardinaud, JP; Favier, JC; Gbikpi-Benissan, G; Gruson, D; Hilbert, G; Portel, L | 1 |
| Fukunaka, N; Ishioka, S; Kobayashi, K; Kudo, R; Minami, M; Nishioka, Y; Sagae, S; Sugimura, M; Terasawa, K | 1 |
1 review(s) available for droperidol and methylprednisolone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
4 trial(s) available for droperidol and methylprednisolone
| Article | Year |
|---|---|
[Randomized crossover trial of the antiemetic effects obtained with metoclopramide and droperidol versus those obtained with metoclopramide, droperidol and methylprednisolone in patients receiving cis-platinum chemotherapy].
Topics: Aged; Cisplatin; Clinical Trials as Topic; Droperidol; Drug Therapy, Combination; Female; Humans; Lung Neoplasms; Male; Methylprednisolone; Metoclopramide; Middle Aged; Nausea; Random Allocation; Vomiting | 1986 |
[Randomized cross-over study on the effects of methylprednisolone, metoclopramide and droperidol on the control of nausea and vomiting associated with cis-platinum chemotherapy].
Topics: Adult; Aged; Cisplatin; Droperidol; Drug Administration Schedule; Female; Humans; Male; Methylprednisolone; Metoclopramide; Middle Aged; Nausea; Random Allocation; Urologic Neoplasms; Vomiting | 1986 |
[A randomized cross-over comparative study of granisetron alone and combination of granisetron, methylprednisolone and droperidol as antiemetic prophilaxis in CDDP-based chemotherapy for gynecologic cancer].
Topics: Adolescent; Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cross-Over Studies; Droperidol; Drug Administration Schedule; Drug Therapy, Combination; Female; Genital Neoplasms, Female; Granisetron; Humans; Methylprednisolone; Middle Aged; Nausea; Ovarian Neoplasms; Uterine Neoplasms; Vomiting | 1997 |
Combination therapy with granisetron, methylprednisolone and droperidol as an antiemetic prophylaxis in CDDP-induced delayed emesis for gynecologic cancer.
Topics: Antiemetics; Antineoplastic Agents; Cisplatin; Cross-Over Studies; Droperidol; Drug Therapy, Combination; Female; Granisetron; Humans; Methylprednisolone; Middle Aged; Nausea; Ovarian Neoplasms; Premedication; Uterine Neoplasms; Vomiting | 2003 |
10 other study(ies) available for droperidol and methylprednisolone
| Article | Year |
|---|---|
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
[Comparison of methylprednisolone and droperidol in the prevention of nausea and vomiting following major gynaecological surgery].
Topics: Adult; Aged; Droperidol; Female; Genital Diseases, Female; Humans; Methylprednisolone; Middle Aged; Nausea; Postoperative Complications; Vomiting | 1991 |
[An antiemetic effect of methylprednisolone plus droperidol against nausea and vomiting caused by administration of high-dose adriamycin to breast carcinoma patients].
Topics: Adult; Antiemetics; Breast Neoplasms; Doxorubicin; Droperidol; Drug Administration Schedule; Female; Humans; Methylprednisolone; Middle Aged; Nausea; Neoplasm Recurrence, Local; Vomiting | 1987 |
[Possibilities of preventing metabolic acidosis during operations using extracorporeal circulation].
Topics: Acidosis; Adolescent; Adult; Anesthesia; Cardiac Surgical Procedures; Child; Child, Preschool; Droperidol; Extracorporeal Circulation; Female; Humans; Infant; Male; Methylprednisolone; Shock | 1982 |
Effective control of cisplatin-induced nausea using high-dose steroids and droperidol.
Topics: Adult; Aged; Cisplatin; Droperidol; Drug Administration Schedule; Drug Therapy, Combination; Humans; Methylprednisolone; Middle Aged; Nausea; Steroids; Vomiting | 1982 |
Malignant hyperthermia and neuroleptic malignant syndrome in a patient during treatment for acute asthma.
Topics: Acute Disease; Adjuvants, Anesthesia; Adult; Anesthetics, Inhalation; Asthma; Bronchodilator Agents; Calcium Channel Blockers; Dantrolene; Droperidol; Glucocorticoids; Halothane; Humans; Intubation, Intratracheal; Magnesium Sulfate; Male; Malignant Hyperthermia; Methylprednisolone; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Neuromuscular Blocking Agents; Respiration, Artificial; Rhabdomyolysis | 1999 |